Dr. Ajay Labroo, FACC, MD

Dr. Labroo practices at St. Luke's Magic Valley Medical Center in Twin Falls, Idaho, part of St. Luke's Health System.

Dr. Labroo's NPI, 1831199371, was assigned on July 27, 2005. Dr. Labroo graduated from University of Illinois College of Medicine - Chicago in 1990. Dr. Labroo holds Florida license ME105331.

Dr. Labroo's primary practice is St. Luke's Magic Valley Medical Center, at 801 Pole Line Road West, Twin Falls, ID 83301 in Twin Falls County. The practice phone is (208) 814-1000.

Dr. Labroo's primary practice is St. Luke's Magic Valley Medical Center in Twin Falls, Idaho, part of St. Luke's Health System. Dr. Labroo is also affiliated with ThedaCare Regional Medical Center-Appleton. The medical group on file is St. Luke's Clinic, Magic Valley/Jerome. Dmand AI also links Dr. Labroo to 5 more hospitals, 8 medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Labroo practices, 12 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Labroo's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Labroo is board certified in interventional cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Labroo's licenses on file in 10 states: Florida, South Dakota, Iowa, Idaho, Illinois, Kentucky, West Virginia, Montana, Wisconsin and Indiana.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, circulation problems and coronary artery disease among the conditions Dr. Labroo treats.

CMS data shows 968 Medicare services from Dr. Labroo across 16 procedure codes in 2024, for 470 Medicare patients. Medicare paid $75,539 for them.

CMS counts 470 Medicare patients who saw Dr. Labroo in 2024. The largest group is 65 to 74, with 181 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Labroo's median patient age at 70, with 50% women.

In 2024, Dr. Labroo wrote 385 Medicare Part D claims for 145 patients. 83% of them were for generic drugs. CMS names the drug for 273 of them, across 12 drugs with 11 or more claims each, at $429,862 in total drug cost. In 2023, CMS named 1,364 claims across 26 drugs.

Dr. Labroo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of coronary angioplasty and stenting by Dr. Labroo, more than 40% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Labroo, published from 2020 to 2021. 2020 was the busiest year, with 3. The most frequent topics are Coronary Artery Disease, Percutaneous Coronary Intervention and Myocardial Infarction. Dr. Labroo has published most often in Coron Artery Dis. Dr. Labroo's most frequent co-authors are Francis Kiet Le, MD, Rahman Shah, MD and Eric J. Dippel, MD.

Dmand AI links Dr. Labroo to 1 clinical trial. Conditions studied include Diabetes Mellitus, Type 2 and Diabetes Mellitus.

CMS Open Payments shows 486 general payments to Dr. Labroo from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 87% of the total. Novartis Pharmaceuticals Corporation paid the most, $105,028.

Dmand AI lists 2 awards for Dr. Labroo, most recently ACC Fellow in 2013.

Dr. Labroo graduated from University of Illinois College of Medicine - Chicago in 1990. Dr. Labroo is a member of ACC.

Dr. Labroo is in network with 21 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.